ADL Pharma
Board
1 director, since incorporationDirector
appointed by deed of 19-01-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 28-08-2026
Mandates through the years
1 name, the dashed line is todayDELENDEKER Anneleen
Director
Director
Board
Mandates as a list
- DELENDEKER Anneleen
- Director, appointed by deed of 19-01-2024, still in office
Control
Founders
DELENDEKER Anneleen, POELMANS Patrick Jos Ludo
This company
ADL Pharma
Equity €45,664
Profit €31,011 in 2025
Capital
- Contribution
- €3,000
- Shares
- 100
- Contribution per share
- €30
- Equity per share
- €457 in 2025
- Source
- deed of 19-01-2024
Articles of association
deed of 19-01-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Voor de helft ten laste van overdrager en voor andere helft ten laste van koper(s),naar evenredigheid met verworven aantal bij meer…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 20:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 19-01-2024 ↗
- DELENDEKER Anneleen 90 shares (90%) · €2,700 in cash
- POELMANS Patrick Jos Ludo 10 shares (10%) · €300 in cash